Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-Muscle Myosin II in Newly Diagnosed Glioblastoma (PR Newswire)
UF startup Myosin Therapeutics has dosed the first patient in its Phase 1/2 glioblastoma trial, advancing the development of a potential new cancer therapy in collaboration with the Mayo Clinic and NCI.
UF Researchers Say Marine Products Show Promising Future In Medical Advancements
Many drug research efforts occurring at UF are focused on marine and natural products that will lead to advancements in medications and treatments for cancers. Dr. Hendrik Luesch was involved in a recent discovery of a marine compound off the east coast of Florida named gatorbulin-1 that could potentially be used in the fight against cancer; this discovery highlights the importance of searching the ocean’s biodiversity.